JEAN-PIERRE BIZZARI
CIK 1630914 · last filed 2026-06-17
JEAN-PIERRE BIZZARI is a corporate insider who has filed 28 SEC Form 4 insider transactions across 5 companies since 2015. The most recent filing, for APRE, was dated Jun 17, 2026. Across all open-market trades the lifetime net is −$1.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $171.2K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$171.2K
5
28
-$1.46M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| APRE | Director | 4,180 | $0.61 | $2.6K | $0 | 3 | 2026-06-17 |
| ADCT | Director | 151,902 | $1.11 | $168.6K | -$20.2K | 5 | 2026-06-03 |
| HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Director | 66,815 | — | — | -$1.44M | 11 | 2023-05-09 |
| PALVELLA THERAPEUTICS, INC. (PIRS) Delisted | Director | — | $13.60 | — | $0 | 5 | 2020-01-28 |
| Celator Pharmaceuticals Inc (CPXX) Delisted | Director | — | — | — | $0 | 3 | 2016-07-12 |
Recent Filings
28 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-17 | APRE | Grant (A) | +3,135 | $0 | EDGAR |
| 2026-06-03 | ADCT | Mixed | +32,400 | -$38.8K | EDGAR |
| 2025-06-17 | ADCT | Tax (F) | −12,600 | -$45.1K | EDGAR |
| 2025-06-09 | APRE | Grant (A) | +1,045 | $0 | EDGAR |
| 2025-06-05 | ADCT | Grant (A) | +40,000 | $0 | EDGAR |
| 2024-06-18 | ADCT | Sell (S) | −6,995 | -$20.2K | EDGAR |
| 2024-06-18 | ADCT | Notice (144) | −6,995 | -$20.2K | EDGAR |
| 2024-06-14 | ADCT | Grant (A) | +40,000 | $0 | EDGAR |
| 2023-08-24 | APRE | Grant (A) | — | $0 | EDGAR |
| 2023-05-09 | HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Grant (A) | +8,065 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.